Antimicrobial Locks for Hemodialysis Catheter Infections
Effect of Tunneled Hemodialysis Catheter Antimicrobial Lock Solution in Prevention of Catheter Related Blood Stream Infection.
1 other identifier
interventional
100
1 country
1
Brief Summary
Tunneled hemodialysis catheters are susceptible to infection with high incidence of complication to the hemodialysis patients .The study aimed to prevent catheter infection through comparing use of antimicrobial solution (Taurolidine) when used as lock solution installed in the lumen of the catheter at the end of the hemodialysis session with the usually used lock solution heparin. The Study was performed on 100 hemodialysis patients over one year in Sohar hospital ,Oman .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Mar 2023
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 24, 2024
CompletedFirst Submitted
Initial submission to the registry
May 4, 2025
CompletedFirst Posted
Study publicly available on registry
July 20, 2025
CompletedJuly 20, 2025
July 1, 2025
1 year
May 4, 2025
July 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison between both groups in terms of incidence of Catheter related blood stream infection
The investigators have studied the incidence of catheter related bacterial infection in both groups to determine superior effectiveness of Taurolidine lock solution than Heparin lock only in terms of prevention of infection .
one year
Secondary Outcomes (1)
Comparison between both groups in terms of treatment cost
one year
Study Arms (2)
Group (A) patients used usual Heparin used as tunneled hemodialysis lock solution
NO INTERVENTIONMeasure incidence of catheter related blood stream infection while patients use Heparin as catheter lock
Group (B) patients used Taurolidine based lock solution as tunneled hemodialysis catheter lock
EXPERIMENTALMeasure incidence of catheter related blood stream infection while patients use Taurolidine based lock solution as catheter lock
Interventions
Taurolidine ,citrate 4% and heparin 500 units per ml used as lock solution in tunneled hemodialysis catheter
Eligibility Criteria
You may qualify if:
- \- All clinically stable adult end stage renal disease patients commence regular hemodialysis through tunneled hemodialysis catheter at Sohar hospital hemodialysis unit.
You may not qualify if:
- Patients with difficult vascular access and the tunneled hemodialysis catheter is the only functioning vascular access .
- Patients with poor flow from the catheter.
- Patients with active infection .
- Patients have displayed allergic reactions to either citrate or taurolidine.
- Patients were taking medication incompatible with either citrate or taurolidine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sohar hospital
Sohar, Sohar, 00968, Oman
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
May 4, 2025
First Posted
July 20, 2025
Study Start
March 1, 2023
Primary Completion
February 29, 2024
Study Completion
July 24, 2024
Last Updated
July 20, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
Methodology and results